Advances in our understanding of Crohn’s disease and ulcerative colitis have led to research that explores new pathways for treating inflammatory bowel disease (IBD). Here are some of the notable new types of therapies that are being evaluated in clinical trials.
Peter Higgins, M.D.
Dr. Peter Higgins, M.D., Ph.D, M.Sc. is the director of the Inflammatory Bowel Disease (IBD) program at the University of Michigan. He received his bachelor's and medical degree from Duke University.
While like any treatment option there are inherent risks for participating in a study, it's essential to understand both the risks and how policies keep patient safety a top priority in clinical trials.